Floatz logo

Therapeutic Asset Ratings

5,098 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Sorafenib
Non-Small Cell Lung Carcinoma
Jian ChenP3B (62)
Syhx2011
Breast Cancer
CSPC Ouyi Pharmaceutical Co., Ltd.P3B (62)
tg103
Obesity Disorder
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.P3B (62)
TIL
Melanoma
City of Hope Medical CenterP3B (62)
Tislelizumab
Classic Hodgkin Lymphoma
Children's Cancer Group, ChinaP3B (62)
Tivozanib
Renal Cell Carcinoma
City of Hope Medical CenterP3B (62)
Vedolizumab
Acute Lymphoblastic Leukemia
City of Hope Medical CenterP3B (62)
Vedolizumab
Acute Myeloid Leukemia
City of Hope Medical CenterP3B (62)
Vibostolimab
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP3B (62)
Volitinib
Hepatocellular Carcinoma
AstraZenecaP3B (62)
XENON
Ischemic Stroke
Negovsky Reanimatology Research InstituteP3B (62)
xw003
Obesity Disorder
Hangzhou Sciwind Biosciences Co., Ltd.P3B (62)
Aducanumab
Alzheimer Disease
BiogenP3B (61)
Adx-324
Hereditary Angioedema
ADARx Pharmaceuticals, Inc.P3B (61)
Anb-002
Hemophilia B
BiocadP3B (61)
Anti-Pd-L1 Monoclonal Antibody Shr-1316
Non-Small Cell Lung Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P3B (61)
Apalutamide
Prostate Adenocarcinoma
Alliance for Clinical Trials in OncologyP3B (61)
Aspirin
Cerebral Atherosclerosis
Population Health Research InstituteP3B (61)
Aspirin
Plasma Cell Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3B (61)
Aspirin
Non-Small Cell Lung Carcinoma
Shanghai Chest HospitalP3B (61)
Atezolizumab
Ovarian Carcinoma
OHSU Knight Cancer InstituteP3B (61)
Atezolizumab
Urothelial Carcinoma
LG ChemP3B (61)
Axitinib
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (61)
Axitinib
Non-Small Cell Lung Carcinoma
Shanghai Pulmonary Hospital, Shanghai, ChinaP3B (61)
Belrestotug
Non-Small Cell Lung Carcinoma
GlaxoSmithKlineP3B (61)
Showing 2501 to 2525 of 5,098 assets
PreviousPage 101 of 204Next